Table 4.
Sensitivity (%) | Specificity (%) | AUC | Cut-off | Asymptotic Sig. | ||
---|---|---|---|---|---|---|
Control vs WCH | IMA | 86.1 | 65 | 0.803 | 38.9 | <0.001 |
T-SH | 80.6 | 77.5 | 0.853 | 0.75 | <0.001 | |
PAB | 72.2 | 67.5 | 0.714 | 0.64 | 0.001 | |
PCO | 63.9 | 67.5 | 0.670 | 1.07 | 0.011 | |
Control vs HT | IMA | 90 | 85 | 0.948 | 47.8 | <0.001 |
T-SH | 87.5 | 85 | 0.926 | 0.69 | <0.001 | |
AOPP | 70 | 70 | 0.765 | 78.1 | <0.001 | |
PAB | 85 | 85 | 0.934 | 0.73 | <0.001 | |
PCO | 70 | 70 | 0.733 | 1.11 | <0.001 | |
8-OHdG | 90 | 80 | 0.925 | 4.71 | <0.001 | |
WCH vs HT | IMA | 87.5 | 69.4 | 0.739 | 56.1 | <0.001 |
T-SH | 70 | 61.1 | 0.691 | 0.61 | 0.004 | |
AOPP | 70 | 69.4 | 0.708 | 79.2 | 0.002 | |
PAB | 77.5 | 69.4 | 0.837 | 0.79 | <0.001 | |
8-OHdG | 87.5 | 75 | 0.877 | 5.64 | <0.001 |
To assess diagnostic accuracy, receiver operating characteristic curve analysis was performed. Area under the curve was then estimated. AOPPs - advanced oxidation protein products; AUC - area under curve; HT - hypertension; IMA - ischemia modified albumin; PAB - prooxidant-antioxidant balance; PCO - protein carbonyl; ROC - receiver operating curve; T-SH - total thiol; WCH - white coat hypertension; 8-OHdG-8-hydroxy-2’-deoxyguanosine. Curves were created for all parameters and their cooperative power to discriminate 2 sets of patients, control and WCH groups, controls and HT, and WCH and HT